Lifecore Biomedical Inc. (LFCR) earnings · $207.1M cap
These earnings events as JSON? API free 100/dayLifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This LFCR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported LFCR revenue for 2026-06-30 was $34.2M. Net income was -$6.2M. Revenue was up 47.3% from 2026-03-31 to 2026-06-30. LFCR currently screens at market cap $207.1M.
When the next LFCR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 47.3% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full LFCR research stays on the stock page; the tape stays on the quote page.
LFCR earnings FAQ
What are LFCR's latest revenue and net income?
Latest cached Lifecore Biomedical Inc. (LFCR) revenue for Jun 30, 2026 was $34.2M. Net income was -$6.2M. Statements: https://lician.com/financials/lfcr
What is LFCR's latest diluted EPS?
Latest cached Lifecore Biomedical Inc. (LFCR) diluted EPS for Jun 30, 2026 was -$0.19.
What period does the latest LFCR earnings print cover?
The latest cached Lifecore Biomedical Inc. (LFCR) earnings print covers Jun 30, 2026. The prior cached period on this page is Mar 31, 2026.
How did LFCR revenue change from the prior cached period?
Cached Lifecore Biomedical Inc. (LFCR) revenue was up 47.3% from $23.2M (Mar 31, 2026) to $34.2M (Jun 30, 2026). Statements: https://lician.com/financials/lfcr
Where are LFCR earnings listed?
Cached earnings facts for Lifecore Biomedical Inc. (LFCR) are listed at https://lician.com/earnings/lfcr. Statements: https://lician.com/financials/lfcr
Not investment advice.